Search results for "Ic testing"

showing 10 items of 283 documents

Secondary findings from whole-exome/genome sequencing evaluating stakeholder perspectives. A review of the literature

2019

IF 2.004 (2017); International audience; With the development of next generation sequencing, beyond identifying the cause of manifestations that justified prescription of the test, other information with potential interest for patients and their families, defined as secondary findings (SF), can be provided once patients have given informed consent, in particular when therapeutic and preventive options are available. The disclosure of such findings has caused much debate. The aim of this work was to summarize all opinion-based studies focusing on SF, so as to shed light on the concerns that this question generate. A review of the literature was performed, focusing on all PubMed articles repo…

0301 basic medicinemedicine.medical_specialtyPatientsGenetic CounselingDisclosure[SDV.GEN.GH] Life Sciences [q-bio]/Genetics/Human genetics030105 genetics & heredityChoice Behavior03 medical and health sciencesSecondary findingsStakeholder ParticipationInformed consentMultidisciplinary approachExome SequencingGeneticsmedicineHumansGenetic TestingMedical prescriptionExomeGenetics (clinical)Literature reviewIncidental FindingsOpinion based studiesModalitiesStakeholderSubject (documents)General Medicine3. Good healthTest (assessment)030104 developmental biologyAttitude[SDV.GEN.GH]Life Sciences [q-bio]/Genetics/Human geneticsFamily medicinePsychologyActionabilityEuropean Journal of Medical Genetics
researchProduct

Clinical whole-exome sequencing for the diagnosis of rare disorders with congenital anomalies and/or intellectual disability: substantial interest of…

2017

International audience; PurposeCongenital anomalies and intellectual disability (CA/ID) are a major diagnostic challenge in medical genetics—50% of patients still have no molecular diagnosis after a long and stressful diagnostic “odyssey.” Solo clinical whole-exome sequencing (WES) was applied in our genetics center to improve diagnosis in patients with CA/ID.MethodsThis retrospective study examined 416 consecutive tests performed over 3 years to demonstrate the effectiveness of periodically reanalyzing WES data. The raw data from each nonpositive test was reanalyzed at 12 months with the most recent pipeline and in the light of new data in the literature. The results of the reanalysis for …

0301 basic medicinemedicine.medical_specialtyPediatricsCongenital anomaliesIntellectual disabilityTranslational researchClinical WES dataCongenital Abnormalities03 medical and health sciencesRare DiseasesIntellectual disabilityDatabases GeneticExome SequencingmedicineHumansExomeGenetic Testing[ SDV.GEN.GH ] Life Sciences [q-bio]/Genetics/Human geneticsExomeGenetics (clinical)Exome sequencingGenetic testingRetrospective Studiesmedicine.diagnostic_testbusiness.industryHigh-Throughput Nucleotide SequencingRetrospective cohort studySequence Analysis DNAmedicine.diseaseAdditional research3. Good health030104 developmental biology[SDV.GEN.GH]Life Sciences [q-bio]/Genetics/Human geneticsWhole-exome sequencingPhysical therapyRaw databusiness
researchProduct

Female obesity increases the risk of miscarriage of euploid embryos.

2020

Objective To determine whether female body mass index (BMI) is associated with an increased risk of miscarriage after euploid embryo transfer. Design A retrospective, observational, multicenter cohort study. Setting University-affiliated in vitro fertilization center. Patient(s) In this study, 3,480 cycles of in vitro fertilization with preimplantation genetic testing for aneuploidy (PGT-A) in the blastocyst stage and euploid embryo transfer were divided into four groups according to patient BMI. Intervention(s) In vitro fertilization with PGT-A. Main Outcome Measure(s) The primary outcome was the miscarriage rate, which included both biochemical and clinical miscarriages. Secondary outcome…

0301 basic medicinemedicine.medical_specialtyPregnancy RateAneuploidyFertilization in VitroRisk AssessmentMiscarriageBody Mass IndexObesity Maternal03 medical and health sciences0302 clinical medicinePregnancyRisk FactorsMedicineHumansEmbryo ImplantationGenetic TestingPreimplantation DiagnosisRetrospective StudiesPregnancy030219 obstetrics & reproductive medicinebusiness.industryObstetricsObstetrics and Gynecologymedicine.diseaseAneuploidyEmbryo TransferEmbryo transferGestational Weight GainAbortion Spontaneous030104 developmental biologyBlastocystTreatment OutcomeReproductive MedicineSpainInfertilityembryonic structuresFemaleUnderweightmedicine.symptombusinessLive birthBody mass indexLive BirthCohort studyFertility and sterility
researchProduct

Reproducibility and concordance of 4 clinically developed programmed death-ligand 1 (PD-L1) immunohistochemistry (IHC) assays in triple negative brea…

2019

Abstract Background Atezolizumab (an anti–PD-L1 antibody) has shown clinical activity alone or in combination with nab-paclitaxel in patients (pts) with first-line metastatic TNBC who have PD-L1 expression on their tumour-infiltrating immune cells (IC). We analysed the performance of 4 PD-L1 IHC assays for PD-L1 IC expression in TNBC. Methods Thirty archival TNBC tissue specimens were selected from a set of 107 based on PD-L1 IC expression per VENTANA SP142 ( 5%: 8 cases), to represent the distribution of PD-L1 IC–positivity in the pivotal atezolizumab studies (Emens et al., SABCS 2018; JAMA Oncol 2019). Serial histologic sections were stained with VENTANA SP142 and SP263, and DAKO 22C3 and…

0301 basic medicinemedicine.medical_specialtybusiness.industryConcordanceStock optionsHematologyIc testing03 medical and health sciences030104 developmental biology0302 clinical medicineTissue specimenOncologyPaclitaxel protein-bound030220 oncology & carcinogenesisFamily medicineComparison studyMedicineIn patientbusinessProgrammed deathAnnals of Oncology
researchProduct

Numerical Methods for BVP’s Appearing in Nondestructive Ultrasonic Testing

2018

Abstract In this article we studies BVP’s that can not be solved as P.V.I or BVP with Matlab solvers ODExx or BVPxx since the solutions do not have limit in 0. We propose a numerical algorithm based on Cubic-spline written in Maple 16 [4].

AcousticsNumerical analysisUltrasonic testingGeneral MedicineBoundary value problemFixed pointMathematicsACTA Universitatis Cibiniensis
researchProduct

ADMISSIBILITY OF GENETIC TESTING INFORMATION BY THE INSURANCE SECTOR IN POLAND

2020

Human progress has led to a growing interest in factors shaping the human nature, physical features, tendencies. Determining the demands of particular nations or social groups influences all industry sectors, the economy, the goods. As this comprehensive sum of the human knowledge plays such a vital role in a modern world, the progress in the field of human genetics and other related sciences will also be accelerated. The wealth of knowledge positively impacts many aspects of life and various types of human activity such as healthcare, the economy, trade. It is evident that the ability to create a detailed analysis of each individual greatly affected the wider insurance sector. The followin…

Actuarial sciencemedicine.diagnostic_testGeneral EngineeringmedicineBusinessGenetic testingRoczniki Administracji i Prawa
researchProduct

Customised next-generation sequencing multigene panel to screen a large cohort of individuals with chromatin-related disorder

2020

BackgroundThe regulation of the chromatin state by epigenetic mechanisms plays a central role in gene expression, cell function, and maintenance of cell identity. Hereditary disorders of chromatin regulation are a group of conditions caused by abnormalities of the various components of the epigenetic machinery, namely writers, erasers, readers, and chromatin remodelers. Although neurological dysfunction is almost ubiquitous in these disorders, the constellation of additional features characterizing many of these genes and the emerging clinical overlap among them indicate the existence of a community of syndromes. The introduction of high-throughput next generation sequencing (NGS) methods f…

Adenosine TriphosphataseAdultMaleCCCTC-Binding FactorTranscription FactorDNA-Binding Proteinchromatin disorderComputational biologyBiologyDNA HelicaseDNA sequencingEpigenesis GeneticMendelian chromatin disordersLocus heterogeneityDe Lange SyndromeGeneticsmedicineCoffin-Lowry SyndromeHumansGenetic Predisposition to DiseaseEpigeneticsGenetic TestingChildGeneGenetics (clinical)Adenosine Triphosphatasesnext generation sequencingepigeneticsGenetic heterogeneityDNA HelicasesMendelian chromatin disorderHistone-Lysine N-Methyltransferasemedicine.diseaseChromatinChromatinDNA-Binding ProteinsMendelian chromatin disorders; epigenetics; next generation sequencingCohortMutationRelated disorderFemaleMyeloid-Lymphoid Leukemia ProteinepigeneticTranscription FactorsHuman
researchProduct

A Comparison of Aspergillus and Mucorales PCR Testing of Different Bronchoalveolar Lavage Fluid Fractions from Patients with Suspected Invasive Pulmo…

2018

ABSTRACT In patients with hematological malignancies, bronchoalveolar lavage fluid (BALF) specimens are commonly used for the diagnosis of mold infections. However, it is not clear whether the cell pellet (P) or the supernatant fraction (S) of the BALF specimen is optimal for molecular diagnostic testing. Thus, 99 BALF specimens were collected from 96 hematology patients with or without allogeneic hematopoietic stem cell transplant. The cell pellets and supernatants were processed alone and in combination (S/P) for testing by two fungus-specific real-time PCR assays compliant with international recommendations. The results achieved with S/P were revealed to be superior in comparison to thos…

Adult0301 basic medicineMicrobiology (medical)Mucoralesmedicine.medical_specialty030106 microbiologyMedizinMycologyReal-Time Polymerase Chain ReactionSensitivity and SpecificityGastroenterologylaw.inventionYoung Adult03 medical and health scienceslawInternal medicinemedicineHumansDNA FungalPolymerase chain reactionAgedAged 80 and overInvasive Pulmonary AspergillosisAspergillusHematologymedicine.diagnostic_testbiologyMolecular Diagnostic Testingbusiness.industryCancerMiddle Agedbiology.organism_classificationmedicine.diseaseFungal diseaseAspergillusBronchoalveolar lavageMolecular Diagnostic TechniquesMucoralesbusinessBronchoalveolar Lavage FluidInvasive Fungal Infections
researchProduct

The clinical utility of PGD with HLA matching: a collaborative multi-centre ESHRE study

2018

Study question Has PGD-HLA been successful relative to diagnostic and clinical efficacy? Summary answer The diagnostic efficacy of PGD-HLA protocols was found lower in this study in comparison to published PGD-HLA protocols and to that reported for general PGD by ESHRE (78.5 vs 94.1% and vs 92.6%, respectively), while the clinical efficacy has proven very difficult to assess due to inadequate follow-up of both the ART/PGD and HSCT procedure outcomes. What is known already The first clinical cases for PGD-HLA were reported in 2001. It is now a well-established procedure, with an increasing number of cycles performed every year. However, PGD-HLA is still offered by relatively few PGD centres,…

Adult0301 basic medicinemedicine.medical_specialtyPediatricsMEDLINEOocyte RetrievalFertilization in Vitro03 medical and health sciences0302 clinical medicinePregnancymedicineHumansGenetic TestingPreimplantation DiagnosisRetrospective StudiesGenetic testing030219 obstetrics & reproductive medicinemedicine.diagnostic_testbusiness.industryHistocompatibility TestingRehabilitationHematopoietic Stem Cell TransplantationPregnancy OutcomeObstetrics and GynecologyRetrospective cohort studyTissue DonorsTransplantationPregnancy rate030104 developmental biologyReproductive MedicineFemaleOutcomes researchbusinessLive birthCohort studyHuman Reproduction
researchProduct

Havep53 gene mutations and protein expression a different biological significance in colorectal cancer?

2002

p53 alterations are considered the most common genetic events in many types of neoplasms, including colorectal carcinoma (CRC). These alterations include mutations of the gene and/or overexpression of the protein. The aim of our study was to assess whether in 160 patients undergoing resective surgery for primary operable CRC there was an association between p53 mutations and protein over-expression and between these and other biological variables, such as cell DNA content (DNA-ploidy) and S-phase fraction (SPF), and the traditional clinicopathological variables. p53 mutations, identified by PCR-SSCP-sequencing analysis, were found in 68/160 patients (43%) and positive staining for p53 prote…

AdultAged 80 and overMaleBase SequenceDNA Mutational AnalysisP53 colorectal cancerDNAMiddle AgedGenes p53ImmunohistochemistryProtein Structure TertiaryGene Expression Regulation NeoplasticMutationHumansFemaleGenetic TestingProspective StudiesIntestinal MucosaTumor Suppressor Protein p53Colorectal NeoplasmsAged
researchProduct